https://www.avient.com/sites/default/files/2023-09/Case Study - Nymax REC - off-road vehicle.pdf
OFF-ROAD VEHICLE MANUFACTURER S T R U C T U R A L B O D Y C O M P O N E N T S • Replace metal and consolidate parts • High strength • Structural stiffness • Durability • Reduced manufacturing complexity while maintaining strength • Leveraged Avient Design services to achieve consolidated part design • Conducted mold flow analysis and guided material selection using technical and application expertise Nymax™ REC Recycled Nylon Formulation – ND 1233 Grade KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-02/complet-lft-bettcher-motor-yoke.pdf
Microsoft PowerPoint - Complet LFT Bettcher Motor Yoke.pptx BETTCHER INDUSTRIES Q U A N T U M ™ M O T O R Y O K E • Reliably support 25-pound motor without deflection • Reduce manufacturing system costs through metal-to- composite conversion • Chemical resistance to withstand corrosive substances during frequent sanitation and during use • Optimized yoke design for new material and performed CAE analysis to confirm reliability • Reduced part weight by nearly 40% • Single-step injection molding fabrication cut lead times and lowered per part costs • Molded-in color eliminated secondary painting and finishing operations Complēt™ Long Glass Fiber Nylon Composite KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-10/Stan Tone HC Plus Menstrual Cups Snapshot.pdf
SILICONE PRODUCT MANUFACTURER M E N S T R U A L C U P S • Biocompatible silicone pigment dispersion that meets healthcare industry material requirements • Custom-colored silicone paste colorant dispersion for liquid silicone rubber (LSR) • Offered a USP Class VI certified, biocompatible silicone colorant dispersion with necessary regulatory support to meet the stringent demands of healthcare product manufacturing • Provided color customization options through personalized communication and high-level technical support Stan-Tone HC Plus Silicone Dispersions for Healthcare KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-04/MAXXAM NHFR Push Buttons Case Study Snapshot.pdf
Appliance Manufacturer APPLIANCE MANUFACTURER P U S H B U T T O N S • Non-halogen to industry standards • Lower density • Good impact properties • Easy to process • High aesthetics • Provided a non-halogenated solution while improving the performance of the formerly used halogenated grade • Supported the project with various expertise in design, regulatory and technical support • Helped to reduce the system cost and make our customer more competitive in the market Maxxam NHFR Non-Halogen Flame Retardant Polyolefin Formulation KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/avient-abac-spanish-spain-200720.pdf
Esta Política es de aplicación para Avient y sus filiales, incluidos todos los directores, empleados y agentes u otros terceros que actúen en nombre de Avient.
Avient no ofrece ni acepta pagos de facilitación o comisiones ilegales de ningún tipo para o de funcionarios gubernamental, clientes, proveedores u otros socios comerciales.
Trabajo con agentes, distribuidores y otros terceros De vez en cuando, Avient puede utilizar los servicios de un agente, distribuidor, consultor u otro intermediario para respaldar sus actividades comerciales, o puede participar con socios comerciales en una empresa conjunta u otra estructura comercial.
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
You can identify these statements by the fact that they do not relate strictly to historic or current facts.
EBITDA $130 million +6% (+7% ex FX)Net Sales $815 million +8% (+8.5% ex FX) Net Sales $815 million +8% (+8.5% ex FX) Q 3 2024 R ES U LT S TOTAL COMPANY (Q3 2024 PERFORMANCE VS Q3 2023) $754 $815 Q3 23 Q3 24 $123 $130 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) $0.57 $0.65 Q3 23 Q3 24 (in millions) Adjusted EBITDA Adjusted EPS 8 + 8% (+8.5% excluding FX) + 6% (+7% excluding FX) + 14% (+16% excluding FX) Sales 9 Q3 2024 RESULTS – ORGANIC REVENUE GROWTH BY REGION VS PY 9 US & Canada Latin America EMEA Asia +9% +5% +11% +27% Avient ex.
FX +8.5% FX -0.4% Total Avient +8.1% Note: Regional Sales Percentages exclude impact of foreign exchange COLOR, ADDITIVES & INKS SEGMENT (Q3 2024 PERFORMANCE VS Q3 2023) $487 $522 Q3 23 Q3 24 $89 $97 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 10 + 7% (+8% excluding FX) + 9% (+11% excluding FX) 18.3% +40 bps *18.7% * * Adjusted EBITDA Margin % • Sales growth driven by winning new product specifications in consumer & packaging, strong underlying demand in healthcare and improving demand in building & construction • Favorable mix and raw material deflation contributed to EBITDA margin expansion SPECIALTY ENGINEERED MATERIALS SEGMENT (Q3 2024 PERFORMANCE VS Q3 2023) $268 $295 Q3 23 Q3 24 $51 $57 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 11 • Sales growth driven by restocking in healthcare & consumer end markets and strong underlying demand for composite applications used in building & construction, energy and defense end markets • Favorable mix contributed to EBITDA margin expansion + 10% (+10% excluding FX) + 12% (+13% excluding FX) 19.0% +40 bps *19.4% * * Adjusted EBITDA Margin % 2024 G U IDA N CE FY 2024 GUIDANCE Previous (Aug 6) Current Adjusted EPS $2.55 to $2.70 $2.63 to $2.67 Adjusted EBITDA $515 to $540 million $525 to $530 million Interest Expense $105 million $104 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures & Investment in S/4 Hana ~$140 million ~$140 million 13 14 • Investor Day to be held December 4, 2024 at the NYSE, beginning at 10AM • The focus will be to do a deep dive on the Company’s strategy • Registration available at www.avient.com/investors 2024 AVIENT INVESTOR DAY AP P EN D IX 17 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 19 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 20 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION US & Canada 52% EMEA 35% Asia 13% 21 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2023 AVIENT REGIONAL SALES Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 22 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-09/Avient Pro Forma Financial Information.pdf
AVIENT CORPORATION P R O F O R M A F I N A N C I A L S F O R D Y N E E M A A C Q U I S I T I O N A N D D I S T R I B U T I O N A S D I S C O N T I N U E D O P E R A T I O N S (NYSE: AVNT) S E P T E M B E R 2 7 , 2 0 2 2 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
You can identify these statements by the fact that they do not relate strictly to historic or current facts.
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Investor Presentation_website w Non-GAAP.pdf
You can identify these statements by the fact that they do not relate strictly to historic or current facts.
Continue fostering our Great Place to Work® culture Strategic ObjectivesStrategic Objectives Long Term Growth Rates Growth DriversGrowth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable GrowthProfitable Growth Great Place to WorkGreat Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- M AY 7 , 2024 W EB CAS T P RE SE N TATI O N 7 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 7 US & Canada Latin America EMEA Asia +2% -6% Flat +2% Avient ex.
FX -1.5% FX -0.5% Total Avient -2.0% Q 1 2024 R ES U LT S Q1 2024 PERFORMANCE VS.
https://www.avient.com/sites/default/files/2021-04/versaflex-hc-bt218-biopharmaceutical-tubing-case-study.pdf
MEDICAL TUBING EXTRUDER B I O P H A R M A C E U T I C A L T U B I N G • Low leachables & extractables • Great tensile performance and kink resistance • Good thermal weldability • Excellent clarity and medical blue tint • ISO 10993-4 & 5, USP Class VI & Animal Derivative Free (ADF) • Supplied drop-in material replacement to overcome supply constraints of incumbent TPE • Offered a lower extractable profile than comparable materials in the market • Enabled easy material transition without changes in tooling or thermal welding machine settings • Formulated solution with proprietary additives to provide clarity and prevent yellowing after sterilization Versaflex™ HC BT218 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-04/Metallic Effect Sulfone case study.pdf
PTFE Wire insulation CONSUMER & AEROSPACE MOLDERS M E T A L L I C - E F F E C T S U L F O N E S O L U T I O N • Metallic appearance • FDA-food contact compliance* • Resistant to repeated washing, steam sterilization, and chemical disinfection cycles • Easy processing to meet flexible design requests • Lightweight to support a reduction in carbon emissions • Created a variety of food contact-approved, brilliant metallic effect colors such as gold, silver, and bronze for optimal aesthetics • Ensured excellent mechanical performance after repeated steam sterilization and harsh chemical cleaning cycles • Offered low MOQ with flexible supply options Colorant Chromatics and BASF Ultrason® high-performance polymers in metallic colors KEY REQUIREMENTS WHY AVIENT?